Arrowhead Pharmaceuticals... (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

14.06

0.17 (1.22%)

At close: May 01, 2025, 3:59 PM

14.35

2.03%

After-hours: May 01, 2025, 07:21 PM EDT

Arrowhead Pharmaceuticals Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Revenue	3.55M	240.74M	243.23M	138.29M	87.99M	168.8M	16.14M	31.41M	158.33K
Cost of Revenue	n/a	n/a	10.42M	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	3.55M	240.74M	232.81M	138.29M	87.99M	168.8M	16.14M	31.41M	158.33K
Operating Income	-601.08M	-205M	-178.51M	-149.04M	-93.16M	61.19M	-55.94M	-37M	-81.74M
Interest Income	22.72M	15.3M	5.03M	6.12M	9.19M	6.96M	n/a	n/a	n/a
Pretax Income	-612.46M	-206.49M	-172.71M	-140.85M	-84.55M	68.15M	-54.45M	-34.38M	-81.72M
Net Income	-599.49M	-205.28M	-176.49M	-140.85M	-84.55M	67.97M	-54.45M	-34.38M	-81.72M
Selling & General & Admin	98.76M	90.93M	124.43M	80.98M	52.28M	26.56M	19.11M	32.02M	41M
Research & Development	505.87M	353.19M	297.31M	206.34M	128.87M	81.05M	52.97M	31.69M	41.45M
Other Expenses	n/a	1.62M	5.8M	2.07M	-582.52K	n/a	7.49K	1.31M	57.35K
Operating Expenses	604.63M	445.74M	421.74M	287.32M	181.15M	107.6M	72.08M	68.4M	79.85M
Interest Expense	32.35M	18.33M	5.03M	6.12M	9.19B	6.96B	1.05B	415.13M	265.79M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	604.63M	445.74M	421.74M	287.32M	181.15M	107.6M	72.08M	68.4M	79.85M
Income Tax Expense	-2.77M	2.78M	3.79M	2K	2.4K	173.55K	2.4K	2.4K	2.4K
Shares Outstanding (Basic)	119.78M	107.31M	105.43M	103.75M	100.72M	93.86M	83.64M	73.15M	60.99M
Shares Outstanding (Diluted)	119.78M	106.75M	105.43M	103.75M	100.72M	98.61M	83.64M	73.9M	61.05M
EPS (Basic)	-5	-1.91	-1.67	-1.36	-0.84	0.72	-0.65	-0.47	-1.34
EPS (Diluted)	-5	-1.92	-1.67	-1.36	-0.84	0.69	-0.65	-0.47	-1.34
EBITDA	-561.51M	-175.67M	-162.29M	-132.58M	-87.22M	65.63M	-51.24M	-29.69M	-78.46M
EBIT	-580.11M	-188.16M	-172.71M	-140.85M	-93.16M	68.15M	-55.94M	-37M	-79.69M
Depreciation & Amortization	18.59M	12.49M	10.42M	8.27M	5.94M	4.44M	4.7M	4.69M	3.26M